2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast CancerBreast Cancer RecurrentActive, not recruitingPhase 32026-09-03NCT03820830
Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM StudiesInvasive Breast Cancer Early StagesRecruitingNot stated2025-05-14NCT03390894